Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

In vitro activity of JPC 2067 alone and in combination with sulfamethoxazole against nocardia species.

Mookherjee S, Shoen C, Cynamon M.

Antimicrob Agents Chemother. 2012 Feb;56(2):1133-4. doi: 10.1128/AAC.05855-11. Epub 2011 Nov 21.

2.

Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey.

Brown-Elliott BA, Biehle J, Conville PS, Cohen S, Saubolle M, Sussland D, Wengenack N, Kriel K, Bridge L, McNulty S, Vasireddy R, Wallace RJ Jr.

J Clin Microbiol. 2012 Mar;50(3):670-2. doi: 10.1128/JCM.06243-11. Epub 2011 Dec 14.

3.

Enhanced in vitro activity of dihydrofolate reductase and dihydropteroase synthase inhibitors in combination against Nocardia spp.

Thielking DM, Destefano MS, Cynamon MH, Yeo AE.

Antimicrob Agents Chemother. 2003 Mar;47(3):1174. No abstract available.

4.

Factors influencing susceptibility of Nocardia species to trimethoprim-sulfamethoxazole.

Bennett JE, Jennings AE.

Antimicrob Agents Chemother. 1978 Apr;13(4):624-7.

5.

In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.

Cercenado E, Marín M, Sánchez-Martínez M, Cuevas O, Martínez-Alarcón J, Bouza E.

Antimicrob Agents Chemother. 2007 Mar;51(3):1102-4. Epub 2006 Dec 28.

6.

Susceptibility profiles of Nocardia isolates based on current taxonomy.

Schlaberg R, Fisher MA, Hanson KE.

Antimicrob Agents Chemother. 2014;58(2):795-800. doi: 10.1128/AAC.01531-13. Epub 2013 Nov 18.

7.

Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.

Lai CC, Tan CK, Lin SH, Liao CH, Chou CH, Hsu HL, Huang YT, Hsueh PR.

J Antimicrob Chemother. 2009 Jul;64(1):73-8. doi: 10.1093/jac/dkp144. Epub 2009 Apr 27.

PMID:
19398458
8.

Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradofloxacin.

Govendir M, Norris JM, Hansen T, Wigney DI, Muscatello G, Trott DJ, Malik R.

Vet Microbiol. 2011 Dec 15;153(3-4):240-5. doi: 10.1016/j.vetmic.2011.06.001. Epub 2011 Jun 15.

PMID:
21726965
9.

In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis.

Vera-Cabrera L, Gómez-Flores A, Escalante-Fuentes WG, Welsh O.

Antimicrob Agents Chemother. 2001 Dec;45(12):3629-30.

10.

In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis.

Tripodi MF, Durante-Mangoni E, Fortunato R, Cuccurullo S, Mikami Y, Farina C, Utili R.

Transpl Infect Dis. 2011 Aug;13(4):335-43. doi: 10.1111/j.1399-3062.2010.00588.x. Epub 2010 Dec 13.

PMID:
21156012
11.

In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing.

Hansen G, Swanzy S, Gupta R, Cookson B, Limaye AP.

Eur J Clin Microbiol Infect Dis. 2008 Feb;27(2):115-20. Epub 2007 Nov 9.

PMID:
17992548
12.

First case of cerebral abscess due to a novel Nocardia species in an immunocompromised patient.

Flateau C, Jurado V, Lemaître N, Loïez C, Wallet F, Saiz-Jimenez C, Decoene C, Bergeron E, Boiron P, Faure K, Guery B, Rodríguez-Nava V.

J Clin Microbiol. 2013 Feb;51(2):696-700. doi: 10.1128/JCM.00762-12. Epub 2012 Dec 5.

13.

Nocardia resistant to trimethoprim- sulfamethoxazole? Maybe not.

[No authors listed]

Clin Infect Dis. 2012 Jul;55(2):iii-iv. No abstract available.

PMID:
22912969
14.

Imipenem-resistant Nocardia cyriacigeorgica infection in a child with chronic granulomatous disease.

Hagerman A, Rodríguez-Nava V, Boiron P, Crisinel PA, Posfay-Barbe KM.

J Clin Microbiol. 2011 Mar;49(3):1185-7. doi: 10.1128/JCM.02073-10. Epub 2010 Dec 22.

15.

[Nocardiosis: clinical and bacteriological aspects. Experience in 16 cases].

Fernández M, Paredes L, Castillo M, Donoso A.

Rev Med Chil. 1987 Nov;115(11):1053-60. Spanish. No abstract available.

PMID:
3509826
16.

Nocardia keratitis: species, drug sensitivities, and clinical correlation.

Lalitha P, Tiwari M, Prajna NV, Gilpin C, Prakash K, Srinivasan M.

Cornea. 2007 Apr;26(3):255-9.

PMID:
17413948
17.

Speciation and susceptibility of Nocardia isolated from ocular infections.

Reddy AK, Garg P, Kaur I.

Clin Microbiol Infect. 2010 Aug;16(8):1168-71. doi: 10.1111/j.1469-0691.2009.03079.x. Epub 2009 Oct 14.

18.

Disseminated and cerebral infection due to Nocardia farcinica: diagnosis by blood culture and cure with antibiotics alone.

Peters BR, Saubolle MA, Costantino JM.

Clin Infect Dis. 1996 Nov;23(5):1165-7.

PMID:
8922819
19.

[Microbiological and clinical features of nine cases with nocardial infections].

Maki Y, Uchida Y, Monji N, Mochimaru T, Morokuma Y, Karashima T, Kiyosuke M, Fujise M, Eto F, Miyake N, Shimono N, Kayamori Y, Kang D.

Rinsho Byori. 2011 Mar;59(3):213-8. Japanese.

PMID:
21560401
20.

In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.

Vera-Cabrera L, Campos-Rivera MP, Escalante-Fuentes WG, Pucci MJ, Ocampo-Candiani J, Welsh O.

Antimicrob Agents Chemother. 2010 May;54(5):2191-3. doi: 10.1128/AAC.01520-09. Epub 2010 Mar 22.

Supplemental Content

Support Center